Tatsuya Suzuki
Taiho Pharmaceutical (Japan)(JP)Aomori University(JP)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Glycosylation and Glycoproteins Research, COVID-19 Clinical Research Studies, Hepatitis C virus research, Carbohydrate Chemistry and Synthesis
Most-Cited Works
- → An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies(2021)286 cited
- → Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2(2021)144 cited
- → SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response(2022)88 cited
- → Regulation of Apoptosis during Flavivirus Infection(2017)86 cited
- → Effective Production of Levulinic Acid from Biomass through Pretreatment Using Phosphoric Acid, Hydrochloric Acid, or Ionic Liquid(2014)68 cited
- → An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo(2022)64 cited